Literature DB >> 28673732

Design, synthesis and biological evaluation of GPR55 agonists.

Lara Fakhouri1, Christopher D Cook1, Mohammed H Al-Huniti1, Linda M Console-Bram2, Dow P Hurst1, Michael B S Spano1, Daniel J Nasrallah1, Marc G Caron3, Larry S Barak3, Patricia H Reggio1, Mary E Abood2, Mitchell P Croatt4.   

Abstract

GPR55, a G protein-coupled receptor, is an attractive target to alleviate inflammatory and neuropathic pain and treat osteoporosis and cancer. Identifying a potent and selective ligand will aid to further establish the specific physiological roles and pharmacology of the receptor. Towards this goal, a targeted library of 22 compounds was synthesized in a modular fashion to obtain structure-activity relationship information. The general route consisted of coupling a variety of p-aminophenyl sulfonamides to isothiocyanates to form acylthioureas. For the synthesis of a known naphthyl ethyl alcohol motif, route modification led to a shorter and more efficient process. The 22 analogues were analyzed for their ability to serve as agonists at GPR55 and valuable information for both ends of the molecule was ascertained.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; GPR55; Homology model; Thiourea; β-Arrestin recruitment assay

Mesh:

Substances:

Year:  2017        PMID: 28673732      PMCID: PMC5752104          DOI: 10.1016/j.bmc.2017.06.016

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  28 in total

1.  Radioligand binding assays and their analysis.

Authors:  Janet J Maguire; Rhoda E Kuc; Anthony P Davenport
Journal:  Methods Mol Biol       Date:  2012

2.  The orphan receptor GPR55 is a novel cannabinoid receptor.

Authors:  E Ryberg; N Larsson; S Sjögren; S Hjorth; N-O Hermansson; J Leonova; T Elebring; K Nilsson; T Drmota; P J Greasley
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

3.  Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.

Authors:  Maria Elena Meza-Aviña; Mary A Lingerfelt; Linda M Console-Bram; Thomas F Gamage; Haleli Sharir; Kristen E Gettys; Dow P Hurst; Evangelia Kotsikorou; Derek M Shore; Marc G Caron; Narasinga Rao; Larry S Barak; Mary E Abood; Patricia H Reggio; Mitchell P Croatt
Journal:  Bioorg Med Chem Lett       Date:  2016-02-16       Impact factor: 2.823

4.  Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.

Authors:  Evangelia Kotsikorou; Karla E Madrigal; Dow P Hurst; Haleli Sharir; Diane L Lynch; Susanne Heynen-Genel; Loribelle B Milan; Thomas D Y Chung; Herbert H Seltzman; Yushi Bai; Marc G Caron; Larry Barak; Mary E Abood; Patricia H Reggio
Journal:  Biochemistry       Date:  2011-06-01       Impact factor: 3.162

5.  Diisobutylaluminum hydride reductions revitalized: a fast, robust, and selective continuous flow system for aldehyde synthesis.

Authors:  Damien Webb; Timothy F Jamison
Journal:  Org Lett       Date:  2011-12-29       Impact factor: 6.005

6.  New synthesis of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid and evaluation of the influence of adamantyl group on the DNA binding of a naphthoic retinoid.

Authors:  Alberto Milanese; Elena Gorincioi; Mehdi Rajabi; Giulio Vistoli; Enzo Santaniello
Journal:  Bioorg Chem       Date:  2011-07-27       Impact factor: 5.275

7.  Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.

Authors:  Peter G Willis; Olga A Pavlova; Svetlana I Chefer; D Bruce Vaupel; Alexey G Mukhin; Andrew G Horti
Journal:  J Med Chem       Date:  2005-09-08       Impact factor: 7.446

8.  GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.

Authors:  Nariman A B Balenga; Elma Aflaki; Julia Kargl; Wolfgang Platzer; Ralf Schröder; Stefanie Blättermann; Evi Kostenis; Andrew J Brown; Akos Heinemann; Maria Waldhoer
Journal:  Cell Res       Date:  2011-04-05       Impact factor: 25.617

Review 9.  Novel cannabinoid receptors.

Authors:  A J Brown
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

10.  Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.

Authors:  Ankur Kapur; Pingwei Zhao; Haleli Sharir; Yushi Bai; Marc G Caron; Larry S Barak; Mary E Abood
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

View more
  4 in total

1.  Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation.

Authors:  Jeremy D Hill; Viviana Zuluaga-Ramirez; Sachin Gajghate; Malika Winfield; Uma Sriram; Slava Rom; Yuri Persidsky
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

2.  Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning.

Authors:  Maria Giovanna Mosca; Maria Mangini; Stefania Cioffi; Pasquale Barba; Stefania Mariggiò
Journal:  Cell Commun Signal       Date:  2021-04-26       Impact factor: 5.712

3.  ChemBead Enabled High-Throughput Cross-Electrophile Coupling Reveals a New Complementary Ligand.

Authors:  Ana L Aguirre; Nathan L Loud; Keywan A Johnson; Daniel J Weix; Ying Wang
Journal:  Chemistry       Date:  2021-07-29       Impact factor: 5.020

Review 4.  Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?

Authors:  Karen J Thompson; Andrew B Tobin
Journal:  Cell Signal       Date:  2020-01-21       Impact factor: 4.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.